Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
about
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1HDL and glucose metabolism: current evidence and therapeutic potentialThe development, past achievements, and future directions of brain PETMild cognitive impairment: diagnosis, longitudinal course, and emerging treatmentsMild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's diseaseNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersEffects of emotionally charged auditory stimulation on gait performance in the elderly: a preliminary study.The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical settingBrain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.Neuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states.Brain Metabolism of Less-Educated Patients With Alzheimer Dementia Studied by Positron Emission Tomography.Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Expression of Tau protein in rats with cognitive dysfunction induced by cerebral hypoperfusionWhite Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.Effects of hypertension and diabetes on sentence comprehension in agingFunctional neuroimaging using F-18 FDG PET/CT in amnestic mild cognitive impairment: A preliminary studyGlucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI.From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution.Mild cognitive impairment: a concept in evolutionPerfusion SPECT and FDG-PET.Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease.[Vascular factors in the pathogenesis of Alzheimer's disease].Evidence for brain glucose dysregulation in Alzheimer's disease.Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.Treatment of Mild Cognitive Impairment.Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review.Computer-aided diagnostic reporting of FDG PET for the diagnosis of Alzheimer’s disease
P2860
Q26800063-C12777D7-DC8D-4C72-9710-44F609E6A26BQ26996502-FC700AF3-B551-40B2-8830-8E718C51B087Q27026331-517244E6-7933-44C6-BF17-7487A93B77C0Q27026362-E61C969D-E59D-4D78-AF25-DBC2FCAE0BE0Q28393932-3333F85A-BEF0-4EBC-BDEB-C00DA10E5CBCQ29615839-C0F975F7-76C1-49CF-82C1-3DCC1A0A9697Q30386903-0CDB908A-1127-46CB-BEC9-8B797A8A8B96Q30830414-199D9959-DE0A-4999-8B5F-5B2C5D747BD3Q31138018-D6978E81-8103-41C0-AF72-54FC9CD49629Q34462406-AA55FAE1-6AEA-4880-9273-A92DCCC96002Q34477727-39C5288B-BF94-4144-B761-EF54332B3809Q34988649-E70A0318-AD5D-41DC-8FB3-98A1E3567280Q35117821-A1D78247-D025-4FDA-A0B5-466955EF8CF2Q35512038-1B8784B7-82D9-4B88-A6A7-70B5CD0E6A35Q36009364-C7B62259-E902-4FA1-BDCD-27BB0BCEC324Q36018654-A58501F3-BA41-45AC-AF5B-44F65D27D8B2Q36330297-A125AE43-A178-4F00-9247-26997BC7E415Q36412428-6BCD4915-9E1E-4CC0-B618-9751D6BE058AQ36437623-4A20BBCF-B813-498E-BAAE-1AD17B685245Q36661005-D4351F6F-ABF2-4D72-8ED5-D6786C860300Q36908006-5464C411-031E-4E00-9808-6CE9C20CAF80Q37293609-AE0BDEB4-55FE-4405-A2E8-89AE4D2B6EB4Q37436607-9D607DC4-1235-483D-B0EA-AC966A85D0DBQ37613576-2D1E0937-F4C3-44CD-8991-4A060E30AB9FQ37653048-283C50D4-4D5D-4E9B-B698-17B047FB9B10Q37668090-2F6B7D7A-CE31-43B7-B86A-C65AFF753E44Q37897692-B72B43E1-AB29-4729-B369-15AD60D08C6BQ37976853-1F9CCC35-3F5F-48C7-8239-4D134BD5BB6EQ38034108-357B32CC-628F-46DD-AA04-6ABB3E477E5AQ38080761-8DD416A2-9300-4B78-BEE1-2E379C1BD961Q38088747-CD2DFC67-8DE6-4877-8C13-318328B5B6EBQ38196884-762932DA-3F3F-4604-8EA7-88143CE263FEQ38435318-A9E664A1-E2BF-4058-B0C0-ADE1D2D9576FQ45955749-B91A4C02-B583-4096-83C4-9416728FFD2AQ47620628-A573CA3B-37D4-4D53-9A69-02C6EF2C6BE1Q48621788-A0AE342B-17C5-44B2-953C-B0C93A601A68Q48715994-EDD47D53-5A3A-498D-BA0D-65B98BE936C0Q50720439-55B48993-BBD5-4653-801D-C447544B2EC5Q51764702-41B2D168-EB5D-49CE-B947-A75A23C096A2Q57741276-AF10EBF1-B1BF-41AA-BF17-FAE85E4272C6
P2860
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
@en
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
@nl
type
label
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
@en
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
@nl
prefLabel
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
@en
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
@nl
P2860
P356
P1476
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
@en
P2093
Karl Herholz
P2860
P304
P356
10.1586/ERN.10.136
P577
2010-11-01T00:00:00Z